Across TCGA pan-cancer cohorts, RNU6-1320P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RNU6-1320P data layer compared with 5 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-1320P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1320P expression acts as an unfavorable survival marker.

KIRP and SKCM are the cancer types where RNU6-1320P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.178	0.867	<.001	6	view →
SKCM	DFS	Median	All	0.046	0.738	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-1320P tumor-vs-normal RNA expression · all RNU6-1320P data types